Netherlands· NL-a3b8ac0a8095

BORTEZOMIB MSN 3,5 mg poeder voor oplossing voor injectie

A bortezomib product containing bortezomib, registered in Netherlands by Vivanta Generics s.r.o.. The same ATC class is registered in 15 of our 19 countries.

ATC L01XG01

Checked against CBG-MEB (Netherlands) on September 29, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about bortezomibAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Bortezomib is registered in 15 of 19 countries.

Countries holding a registration under ATC L01XG01 (bortezomib), each read from that country’s own register.

This record: Netherlands, from CBG-MEB (Netherlands)
8 of them publish a price we can compare per daily dose

Search bortezomib products by name

Bortezomib · ATC L01XG01

15 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Germany
Icelandprice
Ireland
Japan
Netherlands
Norwayprice
Polandprice
Switzerlandprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of bortezomib costs, country by country.

Normalised to the WHO defined daily dose (0.45 mg), so markets compare like for like.

1 market with a comparable price for this class
Public list prices, converted to USD at the rate date shown

Open the full comparison — free account Drug prices for market access

Bortezomib · price per daily dose (0.45 mg)

USD · FX 28 Sept 2026

CH Switzerland$66.46

Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

CBG-MEB (Netherlands)

Active substance: BORTEZOMIB
Manufacturer: Vivanta Generics s.r.o.
Country: Netherlands (NL)
ATC code: L01XG01
ATC class: Bortezomib
Defined daily dose: 0.45 mg, P
Reimbursed: Not published by this register
Source register: CBG-MEB (Netherlands)
Last checked: September 29, 2026

Packs & prices · 1

cbg_meb_id
122048

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

587 interactions on record for bortezomib.

Graded by severity as the source publishes them — 45 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check bortezomib against other medicines How interaction checks work

Bortezomib · interactions on record

587 records

45 severe
250 moderate
66 minor
226 info

Most severe, free to view

MipomersenC10AX11severe
LomitapideC10AX12severe
RifampicinJ04AB02severe
RifabutinJ04AB04severe

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Bortezomib in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All bortezomib products

Authorised across Europe · EMA

The same active substance is authorised in 28 EEA countries. Names it is sold under:

Austria · Abormib, Bortezomib Ever Pharma
Belgium · Bortezomib Eg, Bortezomib Eugia
Bulgaria · Bortezomib Ever Pharma, Бортезомиб Актавис
Cyprus · Bortezomib Pharmazac, Bortezomib Stada
Czechia · Bortezomib Ever Pharma, Bortezomib Msn
Germany · Bortezomib, Bortezomib Amarox
Denmark · Bortezomib Actavis, Bortezomib Ever Pharma
Spain · Bortezomib Aurovitas, Bortezomib Combix
Finland · Bortezomib Avansor, Bortezomib Ever Pharma
France · Bortezomib, Bortezomib Arrow
United Kingdom (Northern Ireland) · Bortezomib, Bortezomib Accord
Greece · Bortezomib Pharmazac, Bortezomib Sandoz
Croatia · Bortezomib Alpha-Medical, Bortezomib Ever Pharma
Hungary · Bortezomib Ever Pharma, Bortezomib Msn
Ireland · Bortezomib Aspire Pharma (Malta), Bortezomib Biotech Pharma Limited
Iceland · Bortezomib Accord, Bortezomib Actavis
Italy · Bortezomib Aurobindo, Bortezomib Dr. Reddy’s
Liechtenstein · Bortezomib Accord, Bortezomib Fresenius Kabi
Luxembourg · Bortezomib Eg
Latvia · Bortezomib Tzf
Malta · Bortezomib Clonmel, Bortezomib Dr. Reddy’s
Norway · Bortezomib Accord, Bortezomib Ever Pharma
Poland · Adabonib, Bortezomib Eugia
Portugal · Bortezomib Ever Pharma, Bortezomib Extrovis
Romania · Bortezomib, Bortezomib Dr. Reddy’s
Sweden · Bortezomib Avansor, Bortezomib Ever Pharma
Slovenia · Bortezomib Actavis, Bortezomib Ever Pharma
Slovakia · Bortezomib Ever Pharma, Bortezomib Glenmark

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/fb173991-3bf8-4b86-85d9-1a586b3e0a82
GET /v1/drugs/fb173991-3bf8-4b86-85d9-1a586b3e0a82?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Poeder voor oplossing voor injectie",
  "route": "Intraveneus gebruik, Subcutaan gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h122048_smpc.pdf",
  "strength": null,
  "atc_label": "Bortezomib",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg122048",
  "excipients": [
    "MANNITOL (D-) (E 421)",
    "STIKSTOF (HEAD SPACE) (E 941)"
  ],
  "substances": [
    "BORTEZOMIB"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h122048.pdf",
  "authorised_at": "2019/03/27",
  "procedure_number": "FI/H/0969/001",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "122048",
  "additional_monitoring": "N"
}

API reference MCP server Plans

See everything about bortezomib.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console